Pretreatment and follow-up variables of patients with type 1 diabetic mellitus undergoing autologous nonmyeloablative hematopoietic stem cell transplantation.

aDuration referred to duration time from appearance of symptoms of hyperglycemia to treatment of AHST (mo);bFBG (mmol/L);cPBG(mmol/L);dHbA1c (%);eGADA (U/mL);fP value, comparison between IF group (patient 1, 2, 3, 4, 6, 9) and ID group (patient 5, 7, 8) using Mann-Whitney test;gC-peptide (ng/mL); - represent the data did not been acquired.

a：病程指从高血糖症状出现至接受AHST治疗的时长，单位为月（mo）；b：空腹血糖（FBG），单位为mmol/L；c：餐后血糖（PBG），单位为mmol/L；d：糖化血红蛋白（HbA1c），单位为%；e：谷氨酸脱羧酶抗体（GADA），单位为U/mL；f：P值，采用曼-惠特尼U检验比较IF组（受试者1、2、3、4、6、9）与ID组（受试者5、7、8）的组间差异；g：C肽（C-peptide），单位为ng/mL；符号“-”代表未获取到对应数据。